Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Prismic Pharmaceuticals Acquires License to Omega 3 Patents - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Prismic Pharmaceuticals Acquires License to Omega 3 Patents

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Prismic Pharmaceuticals, Scottsdale, AZ, has acquired the assets of Scarista Limited, along with Scarista’s exclusive license from Amarin Neuroscience Limited (a wholly owned subsidiary of Amarin Corporation) to develop, market and out-license products based on a portfolio of issued U.S. and foreign composition and use patents covering highly purified forms of omega 3 fatty acids alone or in combination with other molecules for the treatment of disorders of the central nervous system (CNS).

“Having gained access to the robust patents through the acquisition of Scarista, Prismic is planning to partner with one or more pharmaceutical companies in order to maximize the considerable commercial opportunity the patents offer in the CNS area,” said Peter Moriarty, chairman and co-founder of Prismic. “There is already an established body of research and clinical experience indicating the therapeutic benefits and safety of highly purified forms of EPA and DHA for the treatment of cardiovascular disease. There is also similar data relating to their use in the treatment of a number of CNS disorders,” Moriarty added. “Prismic, therefore, believes that any company licensing our IP will have the opportunity to bring patent-protected formulations to market relatively expeditiously.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics